Efficacy of the electronic management system of self monitoring blood glucose in patients with type 1 and type 2 diabetes.

Efficacy of the electronic management system of self monitoring blood glucose in patients with type 1 and type 2 diabetes. - Efficacy of e-SMBG in diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008455

Enrollment

Registered

2012-07-17

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 and type 2 diabetes

Interventions

Type 2 diabetic patients treated with diet or antidiabetics were divided into contorol and e-SMBG groups. Electronic self monitoring sysytem of blood glucose was applied for first 12 weeks (first peri

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetic patients treated with diet or antidiabetics were divided into contorol and e-SMBG 2. Type 1 diabetic patients treated with multiple insulininjection

Exclusion criteria

Exclusion criteria: 1.The patient who was dicided as an inappopritae subject for this study by the physician. 2. Type 2 diabetic patient who has been applied self monitoring blood glucose (SMBG) in recent three months. 2. Type 2 diabetic patient who has been treated with insulin or GLP-1 analogue in recent three months. 4. Type 1 diabetic patients who were treated with insulin without SMBG.

Design outcomes

Primary

Measure	Time frame
the changes of glycated hemoglobin and body weight	—

Countries

Japan

Contacts

Public ContactMunehide Matsuhisa

The University of Tokushima Diabetes Therapeutics and Research Center

matuhisa@tokushima-u.ac.jp088-633-7587

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026